INFORMATIONS RÉGLEMENTÉES
Nyxoah Présente ses Résultats Financiers et d’Exploitation
pour le Troisième Trimestre [...] Read more »
INFORMATIONS RÉGLEMENTÉES
Nyxoah Présente ses Résultats Financiers et d’Exploitation
pour le Troisième Trimestre [...] Read more »
الاتفاقية تفتح المجال أمام علاجات [...] Read more »
CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase 2 clinical–stage biopharmaceutical company [...] Read more »
Agreement creates runway for Profound’s incision–free and radiation–free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East
Read more »
HARARE, Zimbabwe, Nov. 10, 2025 (GLOBE NEWSWIRE) — Namib Minerals (Nasdaq: NAMM) (“Namib Minerals” or the “Company”) today provided an operational update, including production guidance for 2025 [...] Read more »
CALABASAS, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a clinical–stage biopharmaceutical company [...] Read more »
HONG KONG, Nov. 06, 2025 (GLOBE NEWSWIRE) — WeRide (HKEX: 0800.HK, NASDAQ: WRD), a global leader in autonomous driving technology, today announced its successful listing on the Stock Exchange [...] Read more »
Nyxoah to Participate in the Stifel 2025 Healthcare Conference
Mont–Saint–Guibert, Belgium – November 3, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext [...] Read more »
Nyxoah Participera à la Conférence Stifel Healthcare 2025
Mont–Saint–Guibert, Belgique – 3 novembre 2025, 22h05 CET / 16h05 ET – Nyxoah SA [...] Read more »
WAYNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — Read more »